Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20696967)

1.

Impact of biochemical recurrence in prostate cancer among US veterans.

Uchio EM, Aslan M, Wells CK, Calderone J, Concato J.

Arch Intern Med. 2010 Aug 9;170(15):1390-5. doi: 10.1001/archinternmed.2010.262.

PMID:
20696967
2.

Markers and meaning of primary treatment failure.

Swindle PW, Kattan MW, Scardino PT.

Urol Clin North Am. 2003 May;30(2):377-401. Review.

PMID:
12735513
3.

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Simmons MN, Stephenson AJ, Klein EA.

Eur Urol. 2007 May;51(5):1175-84. Epub 2007 Jan 12. Review.

PMID:
17240528
4.

Prostate specific antigen only progression of prostate cancer.

Moul JW.

J Urol. 2000 Jun;163(6):1632-42. Review.

PMID:
10799151
6.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
7.

[PSA follow-up after radical prostatectomy].

Egawa S, Baba S.

Nihon Rinsho. 2002 Dec;60 Suppl 11:284-8. Review. Japanese. No abstract available.

PMID:
12599586
8.

[Serum and urinary PSA in the diagnosis of PSA failure after radical prostatectomy].

Arai Y, Okubo K.

Nihon Rinsho. 2000 Jul;58 Suppl:357-61. Review. Japanese. No abstract available.

PMID:
11022749
9.

Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma.

Gronau E, Goppelt M, Harzmann R, Weckermann D.

Onkologie. 2005 Jun;28(6-7):361-6. Epub 2005 Jun 2. Review.

PMID:
15933426
10.

Prostate-specific antigen as a marker of disease activity in prostate cancer.

Partin AW, Hanks GE, Klein EA, Moul JW, Nelson WG, Scher HI.

Oncology (Williston Park). 2002 Sep;16(9):1218-24; discussion 1224, 1227-8 passim. Review.

11.
12.

Radical prostatectomy in high-risk prostate cancer.

Ischia J, Gleave M.

Int J Urol. 2013 Mar;20(3):290-300. doi: 10.1111/iju.12069. Epub 2013 Jan 10. Review.

PMID:
23305529
13.

Prostate cancer in young men: an important clinical entity.

Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA.

Nat Rev Urol. 2014 Jun;11(6):317-23. doi: 10.1038/nrurol.2014.91. Epub 2014 May 13. Review.

14.

[Cryosurgical treatment for prostate cancer: current state].

Prokhorov DG, Skol'nik MI, Karelin MI.

Vopr Onkol. 2011;57(6):707-16. Review. Russian. No abstract available.

PMID:
22416385
15.

Obesity and prostate cancer: collateral damage in the battle of the bulge.

Thomas JA 2nd, Freedland SJ.

Front Biosci (Schol Ed). 2011 Jan 1;3:594-605. Review.

PMID:
21196398
16.

Obesity and prostate cancer mortality.

Kristal AR, Gong Z.

Future Oncol. 2007 Oct;3(5):557-67. Review.

PMID:
17927521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk